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Introduction: Home-based HIV counselling & testing (HBHCT) is highly acceptable and has the potential
to increase HIV testing uptake in sub-Saharan Africa. However, data are lacking on strategies that can
effectively link HIV-positive individuals identiﬁed through HBHCT to care. This trial was designed to
assess the effectiveness of two brief home-based counselling sessions on linkage to care, provided
subsequent to referral for care among HIV-positive patients identiﬁed through HBHCT in a rural com-
munity in Masaka district, Uganda.
Methods: 28 communities (clusters) were randomly allocated to control (referral only) and intervention
(referral and follow-up counselling) arms (n ¼ 14 clusters/arm). Randomisation was stratiﬁed on distance
from the district capital (10 km vs > 10 km) and cluster size (larger single village vs combined small
villages), and restricted to ensure balance on selected cluster characteristics. A list of possible allocations
was generated and one randomly selected at a public ceremony. HBHCT is being offered to all adults (18
years), and HIV-positive individuals not yet in care are eligible for enrolment. The intervention is pro-
vided at one and two months post-enrolment. Primary outcomes, assessed 6 months after enrolment,
are: the proportion of individuals linking to HIV care within 6 months of HIV diagnosis and time to
linkage. The primary analysis will be based on individual-level data.
Discussion: This study will provide evidence on the impact of a counselling intervention on linkage to
care among adults identiﬁed with HIV infection through HBHCT. Interpretation of the trial outcomes will
be aided by results from an on-going qualitative sub-study.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Access to anti-retroviral therapy (ART) in sub-Saharan Africa has
expanded considerably but AIDS-related mortality remains high
[1]. A major cause of mortality is the late presentation of patients
for care [2,3]. Early ART initiation depends on early HIV diagnosis
through HIV counselling and testing (HCT) and prompt linkage to
care [4]. HCT is essential in expanding HIV prevention and treat-
ment services [5,6], but its uptake in sub-Saharan Africa remains
low [7]. For instance, up to 74% of men and 58% of women in the
region have never been tested for HIV [8].
In sub-Saharan Africa, home-based HIV testing and counselling
(HBHCT) has the potential to substantially increase people's
awareness of their HIV status [9]. HBHCT is highly acceptable
[10e12], cost-effective at reaching previously untested persons
compared with other HCT models [13], promotes equitable access
of services [14] and may promote couples HCT [15,16] and pre-
vention of mother-to-child HIV transmission [16]. Additionally,
HBHCT facilitates early HIV diagnosis and may promote early
linkage to care [16]. However few studies have reported data on
linkage to HIV care after HBHCT [17,18]. Unfortunately, these studies
suggest that without additional strategies to facilitate linkage, less
than half of HIV-positive persons identiﬁed through HBHCT link to
care [18,19]. In contrast, HBHCT studies in which such linkage
strategies were used showed an increase of linkage of up to 90%
[20e25]. However, most of these were uncontrolled observational
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studies. There is a need for rigorous evaluation of promising linkage
strategies, using randomised controlled trials in order to identify
the most effective approach.
Follow-up counselling after HIV diagnosis and referral is one of
the strategies that has been utilised to facilitate linkage to care
[21,24,25]. Counselling may mitigate psychosocial barriers of link-
age to care [26]. For instance, counselling facilitates disclosure of
HIV positive status [27]. In turn, disclosure makes it possible for the
patient to receive psychosocial support, a key facilitator of linkage
to care [28]. Follow-up counselling may also be used to provide
information about ART, other care services and encourage linkage
to care [29]. It is also a relatively simple strategy that may be
delivered through non-medical personnel [30,31], which makes it
feasible also in low resource settings. We describe an ongoing
cluster randomised controlled trial of follow-up counselling after
referral to HIV care, compared to referral only, among individuals
diagnosed with HIV infection through HBHCT in Masaka district,
Uganda.
1.1. Study objectives and outcomes
The objective of the study is to determine the effectiveness of
follow-up counselling on linkage to HIV care, deﬁned as active
registration with an HIV clinic. Primary outcomes are: the propor-
tion of individuals linking to care within 6 months of HIV diagnosis
through HBHCT, and time between HIV diagnosis and linkage to
care. Secondary outcomes include time between HIV diagnosis and
receipt of CD4 cell count test results, time between HIV diagnosis
and ART initiation, and the proportion of participants who report
adherence to daily cotrimoxazole prophylaxis 6 months after HIV
diagnosis. A further secondary outcome is the proportion of HIV-
negative participants who agree to repeat HIV testing 6 months
after HBHCT.
2. Methods
2.1. Study design and population
2.1.1. HIV-positive participants
The study is an open-label cluster randomised controlled trial
being conducted in three rural sub-counties in Masaka district,
Uganda. It is based at the MRC/UVRI Unit station in Masaka. The
study population consists of newly and previously diagnosed HIV-
positive adults (18 years) identiﬁed through HBHCT who are not
in care and are willing to provide informed consent and receive
follow-up counselling at home. Exclusion criteria include: previ-
ous/current receipt of HIV care, on-going participation in other
health-related research, planned change of residence in the next 6
months, and inability to provide informed consent.
2.1.2. HIV-negative participants
HIV-negative adults (18 years) who are willing to provide
informed consent, receive follow-up counselling at home, and have
no intention of changing residence in the next 6 months are
recruited from each randomised community primarily to reduce
the possibility of revealing the HIV positive status of the main trial
participants. Data from these participants will also be used to
investigate whether follow-up counselling increases the uptake of
repeat HIV testing.
2.2. Identiﬁcation and selection of clusters
Clusters comprised one or more villages i.e. the smallest
administrative areas. All villages (n ¼ 158) in the study area were
mapped (Fig. 1) and the number of adults in each village obtained
(range: 50e1500). To ensure a reasonable number of eligible par-
ticipants in each cluster, we combined small (<400 adults) villages
with adjacent villages into larger clusters of at least 400 adults.
Therefore, a cluster was deﬁned as a village or a set of villages with
at least 400 adults. Clusters were separated by a buffer zone of at
least one non-participating village to minimise the risk of
contamination.
2.3. Sample size estimates
Sample size was calculated to ensure adequate power to address
the hypothesis that follow-up counselling would increase the
proportion of individuals that link to care. Based on previous
studies in the area [32,33], we assumed an adult HIV prevalence of
10%. The 2011 Uganda national HIV sero-prevalence survey
(Masaka district was included in the survey) found that 60% of HIV-
positive adults are unaware of their HIV status and are therefore not
in care [33]. However, anticipating increased HCT coverage since
the survey, we adjusted this ﬁgure to 40%. Based on these ﬁgures
and the population estimates from the mapping data (harmonic
mean of 525 adults in each cluster), we estimated that the har-
monic mean number of HIV-positive persons who would not be in
care in a cluster was 21 (i.e. 525  0.10  0.40). After further
adjusting for persons who would be excluded due to ineligibility or
refusal to participate (10%) as well as loss to follow-up (10%) after
enrolment, we estimated that the harmonic mean number of in-
dividuals completing the study in each cluster would be 17.
We assumed a between cluster coefﬁcient of variation, k, of 0.25.
This was based on past studies of linkage to HIV care [22,34,35] that
were conducted in settings similar to Masaka in which k ranged
from 0.12 to 0.33. We assumed linkage of 35% in the control arm
based on ﬁndings from earlier HBHCT studies [36e39]. The esti-
mated intervention effect was based on ﬁndings from HBHCT
studies that have used follow-up counselling to facilitate linkage to
care in Uganda [21,22]. Using methods for stratiﬁed cluster rand-
omised trials [40], and assuming a k of 0.25 and a harmonic mean of
17 participants completing the study in each cluster, we estimated
that 11 clusters per arm would be required to have 90% power to
detect an increase in linkage to care from 35% in the control arm to
60% in the intervention arm as statistically signiﬁcant (p < 0.05).
This sample size would also give us 95% power to detect a hazard
ratio of 1.7 for the effect of the intervention on time to linkage, or
80% power to detect a hazard ratio of 1.5 [41].
After completing enrolment in the ﬁrst seven clusters, we
observed that 12% (419/3546) of registered resident adults from the
mapping exercise were not found at home and could not be con-
tacted in spite of repeated attempts. Of those found at home, 11%
(358/3127) declined to have HBHCT. Furthermore, among HIV pos-
itive persons, therewas a higher than expected level of engagement
in HIV care: only 26% (75/294) of those who tested positive in
HBHCT were not in care. As a result, the number of participants
enrolled per cluster was much lower (harmonic mean < 10) than
anticipated. Based on these preliminary ﬁndings, the number of
clusters was increased to 28 (14 per arm) with an expected har-
monic mean of 7 participants completing the study in each cluster;
this would allow for detection of the same difference in proportions
with a power of 83%, or a hazard ratio of 1.7 with a power of 85%.
2.4. Randomisation of clusters
We used a combination of stratiﬁcation and restriction in order
to minimise between-cluster variation and achieve overall balance
between study arms with regard to key variables. First, random-
isation was stratiﬁed on distance (10 km or >10 km) from the
Masaka district capital, as this may inﬂuence accessibility to HIV
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Fig. 1. Study clusters.
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care, and on cluster make-up, i.e. whether the cluster was
composed of a single large village or several small villages: 70,560
possible allocations (possible ways in which clusters could be
randomised to intervention or control arms) were generated under
the stratiﬁed design. Restricted randomisation was then applied to
achieve balance on the following covariates: cluster size; presence
of a trading centre; location along a major road; lakeshore location;
and presence of an HIV clinic within 5 km. The tolerance thresholds
for balance were deﬁned through an iterative process in which
different thresholds were tried and the number and the validity of
the acceptable allocations examined. Of the possible allocations
under the stratiﬁed design, 28,932 (41%) were found to satisfy the
additional balance criteria after restriction. Of these, a list of 1000
acceptable allocations was randomly generated from which one
was selected at public randomisation ceremony. Each allocation
had a unique running number.
2.4.1. Public randomisation ceremony
The ceremony was held on 13th March 2015 and attended by
1e2 leaders from each of the villages. Three sacks each containing
10 balls labelled 0 to 9 were prepared, representing allocations 001
to 999, and 000 representing 1000. The principle underlying the
random selection procedure was carefully explained in simple
words. Three community leaders, selected by their peers, were then
invited and one after the other each asked to draw one ball from
one sack (3 balls total) thus generating a 3-digit number, corre-
sponding to the allocation running number on the list. The six
clusters added later were treated as a separate stratum. Possible
allocations for these clusters were generated using the same pro-
cedure described above and one allocation selected at a second
public randomisation ceremony on 30th June 2015.
2.5. Study interventions
Participants in the control and intervention clusters receive
HBHCT and a written referral to an HIV care clinic of their choice if
found to be HIV-positive. In addition, participants in the interven-
tion clusters receive two follow-up counselling sessions at their
home, delivered within 2 months after testing. Each session lasts
about 45 min. The counselling intervention is designed to address
common previously described psychosocial barriers of linkage to
HIV care such as stigma [42e45], non-disclosure of HIV status
[34,46,47], denial of HIV diagnosis [43,45,47], misconceptions
about antiretroviral drugs (ARV) [26,30,45], and fear of their side
effects [26,30], lack of partner [45,48] and other social support
[34,47,49], and misconceptions about ART provider practices
[45,49]. The content of the counselling intervention includes: a
discussion of the individual's acceptance of HIV diagnosis, experi-
ence of stigma, plans to seek care and support services, importance
of HIV status disclosure and psychosocial support for linkage to and
retention in care; and provision of information about local HIV care
services, ARVs, and rationale for early linkage to care. In keeping
with previous observational studies of linkage to care interventions
[21,22,25,29], follow-up counselling in our study is conducted at
one and two months after HBHCT. HIV-negative participants in the
intervention arm are offered home-based risk reduction counsel-
ling and encouraged to seek regular HIV testing.
2.6. Study procedures
A summary of the study procedures is provided in Table 1.
2.6.1. Preparatory phase
Mapping of the study area, community mobilisation meetings,
staff recruitment and training, setting up of referral tracking and
linkage veriﬁcation procedures with HIV care providers were con-
ducted in the three months prior to study initiation. In each cluster,
additional community mobilisation is conducted one week prior to
HBHCT.
2.6.2. Screening and enrolment
Accompanied by a community guide, study counsellors visit all
the households in the randomised clusters, enumerate all resident
adults aged 18 years and offer them HBHCT. HCT is conducted in
accordance with national guidelines [50]. Married/cohabiting in-
dividuals are given the option of couple or individualised HCT.
Identiﬁed HIV-positive individuals who are not yet in care are given
a written referral letter (a copy is retained for the study ﬁle) to take
to their preferred HIV care provider for initiation of cotrimoxazole
prophylaxis, CD4 count testing (results available within 4 weeks),
and ART initiation if eligible under national guidelines (CD4
<500 cells/mL). Additionally, they are given detailed information
about the study and invited to consent and participate. After
obtaining consent, the individual's eligibility for the study is
assessed, he/she is enrolled if eligible, and informed of his/her
cluster allocation. A questionnaire is then administered to collect
data on socio-demographic characteristics and history of previous
HIV testing history. Households in which some or all adults are not
at home are revisited at least two more times.
Once 3e4 HIV-positive participants are enrolled, enrolment is
also offered to the ﬁrst consenting person that tests HIV negative in
the next household. We expect to recruit at least 84 HIV-negative
participants.
2.6.3. Participant follow-up
There are four post-enrolment home-based follow-up visits.
 Months 1 and 2 (intervention arm only): to provide follow-up
counselling.
 Month 6: to collect data on linkage to care and other outcomes,
perform CD4 cell count testing for participants who have not
had a CD4 count test at an HIV clinic or are not aware of the
result, and repeat HCT for HIV-negative participants. CD4 cell
count and repeat rapid HIV tests are conducted at theMRC/UVRI
laboratory in Masaka town. Repeat rapid HIV tests are con-
ducted at the laboratory instead of participants' homes in order
to make the procedures for HIV-positive and HIV-negative
participants as similar as possible and thus minimise the risk
of revealing participants' HIV status.
 Month 6 þ 1 week: to provide CD4 cell count or repeat HIV test
results.
Participants not found at home at any of the post-enrolment
visits are revisited at least two more times.
2.6.4. Collection of outcome data
Outcome data are collected using two methods: Firstly, a
questionnaire is administered by the counsellor to collect infor-
mation on whether and when the participant linked to care, pro-
vided a blood sample for CD4 cell count testing and received the
results, was informed of his/her ART eligibility and initiated ART,
initiated cotrimoxazole prophylaxis andwhether he/she adhered to
cotrimoxazole prophylaxis. Good adherence to cotrimoxazole
prophylaxis is deﬁned as self-report of having taken >80% (25) of
30 doses in the past month. Secondly, clinic records are reviewed,
looking for a participant's referral letter and medical forms, and
pre-ART and/or ART register books to verify self-reported linkage
and other outcomes. Participants whose records are not found at
the HIV clinic are re-contacted, informed of the veriﬁcation
outcome, and asked to clarify if they actually registered for care or
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not. Except for adherence to cotrimoxazole, which is not recorded
in the clinic records, only veriﬁed data will be used for the analysis
of primary and secondary outcomes.
2.6.5. Data management
Data are collected using paper-based questionnaires. Before
data entry, questionnaires are checked for completeness and logical
consistency. Data are double-entered and validated in Microsoft
Access. Queries are run on the entered data every fortnight and
reports sent to the study team for resolution. Data arising from the
resolved queries are resubmitted for entry and the process is
repeated until no more queries are generated.
2.7. Analysis plan
Analyses will be by intention to treat and based on individual-
level data, since there is a reasonable number of clusters per arm
and the cluster size varies considerably [51]. Random effects logistic
regression and Cox regression with shared frailty will be used to
estimate the effect of the intervention on the proportion of par-
ticipants linking to care and time to linkage, respectively. Likeli-
hood ratio tests will be performed for hypothesis testing. Similar
methods will be used to estimate the effect of the intervention on
the proportions of participants that adhere to cotrimoxazole pro-
phylaxis and undergo repeat HIV testing, and on the time to receipt
of CD4 count results, and ART initiation. The primary analysis of the
intervention effect for all outcomes will be adjusted for random-
isation stratum as a ﬁxed effect. Exploratory analyses adjusting for
age and sex a priori, and other characteristics that show substantial
baseline imbalance, will also be carried out. Although the primary
analyses will be based on individual-level approaches, analyses
based on cluster-level approaches will also be performed to check
the robustness of the results. Kaplan-Meier methods will be used to
calculate time to linkage, receipt of CD4 count results, and ART
initiation in each arm. Median and interquartile ranges for time to
these outcomes will be estimated. A detailed statistical analysis
plan will be prepared prior to data analysis.
Ethical approval
The initial study protocol and subsequent amendments were
approved by Uganda Virus Research Institute Research Ethics
Committee (GC/127/14/12/491), the Uganda National Council for
Science and Technology (HS 1732), and The London School of Hy-
giene and Tropical Medicine Ethics Committee (8833). Written
informed consent (including consent to track referrals and review
medical records for persons who link to care) is obtained from each
participant before study procedures are conducted. The trial is
registered at ClinicalTrials.gov (NCT02497456).
3. Discussion
This study is one of the few randomised trials from sub-Saharan
Africa designed to evaluate the effect of an intervention to increase
linkage to HIV care following HIV diagnosis through HBHCT. We are
aware of ﬁve other such trials. The ﬁrst is a recently completed
individually randomised controlled trial from South Africa and
Uganda that assessed whether community-based HIV testing
(including HBHCT) with counsellor support (home-based follow-up
counselling and accompanied referral) and POC CD4 cell count
testing increases uptake of ART. In this trial, linkage to care was
high (89%) across all linkage strategies used [20]. The second is a
completed but not yet reported individually randomised trial from
rural western Kenya aiming to assess the accuracy, feasibility and
acceptability of point-of-care (POC) CD4 testing for persons found
HIV positive through HBHCT, and to determine the (cost-) effec-
tiveness of this intervention in improving linkage to care and time
to ART initiation [52]. The third is an ongoing cluster randomised
trial in rural Uganda to evaluate the effectiveness of linkage to care
counselling in achieving HIV viral suppression and to determine
intermediate outcomes (linkage, time to initiation of opportunistic
infection prophylaxis, and time to initiation of ART among people
testing HIV positive during HBHCT) [53]. The fourth is an ongoing
household randomised trial in rural Lesotho to evaluate the effec-
tiveness of same day home-based ART initiation after HIV diagnosis
coupled with a reduced frequency of clinic follow-up visits in
improving linkage to care, retention in care, and viral suppression
[54]. The ﬁfth is a planned individually randomised trial in western
Kenya that will compare home and other community recruitment
strategies, HIV testing strategies (self-testing, HCT in a home/mo-
bile setting, and facility-based HCT), and different linkage strategies
(referral only, text message reminder, and ﬁnancial incentive) to an
adaptive (SMART trial design) linkage to care intervention, among
young at-risk women [55]. Primary outcomes for this trial include
uptake of recruitment strategies, uptake of testing modalities,
linkage to and retention in care.
A major strength of our trial is that referrals for care are tracked
and medical records examined to verify self-reported linkage.
Hence it is unlikely that the proportion of persons linking to care
will be overestimated. Despite concerns about inadequate routine
Table 1
Study procedures.
Procedure 3 months 1 week Month 0 Month 1 Month 2 Month 6 Month 6 þ 1 week
Mapping & identiﬁcation of clusters X
Community mobilisationa X X
Recruitment and training of staff X
Set up of referral tracking and linkage veriﬁcation procedures X
Census & HBHCT X
Study information & informed consent X
Eligibility screening & enrolment X
Collection of socio-demographic data X
Referral for care X
Follow-up counselling (Intervention arm) X X
Collection of outcome data (participant interview) X
Collection of outcome data (review of HIV clinic records) X
Sample collection for CD4 cell count testingb X
Sample collection for repeat HIV testing X
Delivery of CD4 cell count and repeat HIV test resultsc X
a Community mobilisation activities are conducted up to one week before onset of HBHCT in each cluster.
b CD4 count testing is done for participants who have not had a CD4 count test or are not aware of the result.
c Testing is conducted at the MRC/UVRI in Masaka town.
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record keeping at health care facilities in Uganda [56], we have so
far not encountered such a problem at HIV care clinics. All infor-
mation on reported linkage collected and analysed to date have
either been veriﬁed by clinical records, or have been withdrawn as
false when individual patients were re-interviewed in case of dis-
crepancies. Participants who self-report not linking to care are not
tracked further, as it is unlikely that individuals would link to care
but choose to report otherwise.
We randomised communities instead of individuals in order to
minimise the risk of contamination between trial arms e.g. through
sharing of follow-up counselling information, which would result
in a dilution of intervention effects. Also, individual randomisation
may not have been acceptable to participants especially if they
perceive one of the interventions to be inferior to the other.
The study has some limitations. First, some individuals in the
study communities may have knowledge of their cluster allocation
which may inﬂuence their decision to enrol in the study. In-
dividuals may obtain prior knowledge of cluster allocation through
community leaders who attended the pre-enrolment public ran-
domisation ceremony or from those in the same community who
have enrolled before them. Tominimise the effect of this potentially
differential enrolment, individuals are only informed of their
cluster allocation after they have consented and enrolled in the
study. Additionally, within each village, participants are enrolled
over 2e4 days, tominimise the time available for individuals to ﬁnd
out their allocation from fellow village residents. Related to this is
the risk of differential loss to follow-up after enrolment e.g. because
different proportions of participants may withdraw from the trial
after becoming aware of their allocation. To mitigate against this,
part of the eligibility criteria is “availability for the entire duration
of the study and willingness to be followed up at home”. Partici-
pants who indicate that they will not be available for follow-up are
excluded from the study. Second, despite the creation of buffer
zones between clusters, there might still be a risk of contamination
resulting from possible interaction between study participants
from different trial arms. Data on the occurrence of such interaction
is collected at the month-6 visit; the results will be reported along
with the main trial ﬁndings.
We did not include a component to evaluate cost-effectiveness
of the home-based follow-up intervention. Such evaluation may
be necessary to inform policy if the intervention is found to be
effective. However, given the fact that it is a relatively simple
intervention, the costs of incorporating it into the routine HBHCT
work are likely to be minimal.
Whereas quantitative methods such as those used in our trial
are appropriate for investigating the effect of a health care inter-
vention, a qualitative exploration of experiences, attitudes, beliefs
and understandings is needed to ﬁnd out why the intervention
works or does not work [57,58]. For this reason, a qualitative sub-
study is being conducted in both trial arms in a sub-set of partici-
pants who linked successfully to care and others who did not in
order to better understand the reasons for linkage or lack of linkage
to HIV care.
This study will contribute evidence on the impact of referral
plus home-based follow-up counselling on linkage to care, as
compared to only referral among adults identiﬁed with HIV infec-
tion through HBHCT in Uganda. Interpretation of trial outcomes
will be aided by ﬁndings from the qualitative sub-study.
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